title: [Beta-blockade--a new therapeutic modality in chronic heart insufficiency].
abstract: Heart failure due to decreased left ventricular function is a condition with a considerable morbidity and mortality. Until recently beta-blocker treatment has been considered contraindicated in this condition. During the last 20 years a number of investigations have pointed to a possible positive effect of beta-blocker treatment in chronic heart failure and recently several major randomized trials have shown a significantly increased survival during beta-blocker treatment. This review summarizes the background for the use of beta-blocker treatment in chronic heart failure patients.
authors.affiliation: g.jenson@dadlnet.dk
authors.forename: G
authors.initials: G
authors.lastname: Jensen
authors.forename: S
authors.initials: S
authors.lastname: Boesgaard
authors.forename: J
authors.initials: J
authors.lastname: Aldershvile
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D016032:Randomized Controlled Trials as Topic
chemical_list: D000319:Adrenergic beta-Antagonists